We are live on ! Find out more
MRSN

Mersana Therapeutics

Delisted

MRSN was delisted on the 5th of January, 2026.

157 hedge funds and large institutions have $437M invested in Mersana Therapeutics in 2023 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,243% more call options, than puts

Call options by funds: $8.89M | Put options by funds: $662K

30% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 20

16% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 44

3% more funds holding

Funds holding: 152157 (+5)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.11% less ownership

Funds ownership: 4.06%3.95% (-0.11%)

26% less capital invested

Capital invested by funds: $590M → $437M (-$153M)

Holders
157
Holders Change
+5
Holders Change %
+3.29%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
26
Increased
51
Reduced
44
Closed
20
Calls
$8.89M
Puts
$662K
Net Calls
+$8.23M
Net Calls Change
+$8.18M
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$37M
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$35.6M
ACA
3
Avoro Capital Advisors
New York
$31M
BlackRock
4
BlackRock
New York
$30.7M -$102K -724 -0.2%
State Street
5
State Street
Massachusetts
$26.4M +$3.12M +22,247 +9%
Vanguard Group
6
Vanguard Group
Pennsylvania
$19.1M +$1.06M +7,578 +4%
BG
7
Bellevue Group
Switzerland
$17.7M +$95.6K +681 +0.4%
RSCM
8
Rock Springs Capital Management
Maryland
$16.9M
SCM
9
Sarissa Capital Management
Connecticut
$15.6M -$1.11M -7,880 -5%
APM
10
Avidity Partners Management
Texas
$14.1M +$19.3M +137,329 New
B
11
Braidwell
Connecticut
$13.8M +$8.38M +59,724 +80%
Goldman Sachs
12
Goldman Sachs
New York
$12.1M +$5.19M +37,002 +46%
CS
13
Candriam SCA
Luxembourg
$11.2M +$1.52M +10,800 +10%
Marshall Wace
14
Marshall Wace
United Kingdom
$10.3M -$153K -1,091 -1%
AG
15
Artal Group
Luxembourg
$9.11M +$88.7K +632 +0.7%
Morgan Stanley
16
Morgan Stanley
New York
$7.8M +$790K +5,626 +8%
BBA
17
Baker Bros. Advisors
New York
$7.75M +$10.6M +75,445 New
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$7.42M -$2.97M -21,194 -23%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$7.39M +$513K +3,655 +5%
Millennium Management
20
Millennium Management
New York
$5.18M -$13.5M -96,099 -66%
Renaissance Technologies
21
Renaissance Technologies
New York
$5.14M +$3.81M +27,152 +119%
N
22
Nuveen
North Carolina
$5.1M +$67.8K +483 +1%
ABG
23
Ally Bridge Group
New York
$4.9M
5VM
24
5AM Venture Management
California
$4.87M +$6.65M +47,400 New
Deutsche Bank
25
Deutsche Bank
Germany
$4.72M +$94.6K +674 +1%